Acrivon Therapeutics, Inc. Common Stock (ACRV) Live Share Price, Invest From India

Acrivon Therapeutics, Inc. Common Stock Stock Performance

as on April 22, 2026 at 6:59 am IST

Day's Low
Day's High
$1.75
Day's Price Range
$1.87
$1.76
0.57%
Downside
6.25%
Upside
52 Week's Low
52 Week's High
$1.05
52-Week Price Range
$3.56
$1.76
40.34%
Downside
102.27%
Upside

Acrivon Therapeutics, Inc. Common Stock share price movements today

Previous Close: $1.86
Open: $1.85
Volume: 887.8K
Day's Low - High: $1.75 - $1.87
52 Week Low - High: $1.05 - $3.56

Acrivon Therapeutics, Inc. Common Stock Historical Returns

1 Month Return: + 12.05 %
3 Month Return: -11 %
1 Year Return: -2.62 %
3 Year Return: -84.16 %
5 Year Return: 0 %

Acrivon Therapeutics, Inc. Common Stock Stock Fundamentals & Key Indicators

Check Acrivon Therapeutics, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$69.0M

EPS (TTM)

-2.0686

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-82.8M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-53.86%

Acrivon Therapeutics, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Acrivon Therapeutics, Inc. Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Acrivon Therapeutics, Inc. Common Stock	BUY	$69.0M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$41.3B	126.09%	133.47	8.45%
Vertex Pharmaceuticals Inc	BUY	$111.7B	99.85%	28.65	32.94%
BeiGene, Ltd.	NA	$36.5B	NA	128.25	5.37%
Regeneron Pharmaceuticals Inc	BUY	$79.2B	47.96%	18.05	31.41%

Stock Returns calculator for Acrivon Therapeutics, Inc. Common Stock Stock including INR - Dollar returns

The Acrivon Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Acrivon Therapeutics, Inc. Common Stock investment value today

Current value as on today

₹1,01,152

Returns

₹1,152

(+1.15%)

Returns from Acrivon Therapeutics, Inc. Common Stock Stock

-₹7,853 (-7.85%)

Dollar Impact

₹9,006 (+9.01%)

Analyst Recommendation on Acrivon Therapeutics, Inc. Common Stock Stock

Based on 16 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Acrivon Therapeutics, Inc. Common Stock. Average target price of $11.5

Acrivon Therapeutics, Inc. Common Stock Share Price Target

Get share price movements and forecasts by analysts on Acrivon Therapeutics, Inc. Common Stock.

What analysts predicted

84.7%UPSIDE

Target Price

$11.5

Current Price

$1.76

Analyzed by

16 Analysts

Target

$11.50

Acrivon Therapeutics, Inc. Common Stock target price $11.5, a slight upside of 84.7% compared to current price of $1.76. According to 16 analysts rating.

Acrivon Therapeutics, Inc. Common Stock Stock’s Investor Sentiment and Interest

Search interest for Acrivon Therapeutics, Inc. Common Stock Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.

Time period: March 23, 2026 to April 22, 2026

Change:-28% versus previous 30 day period

Acrivon Therapeutics, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	1	-	-	-	0	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-16	-21	-17	-21	-25	-24	-21	-22	-19	-20
EBITDA	-16	-19	-17	-21	-24	-22	-19	-20	-17	-26
Interest Expense	-	1	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-14	-19	-16	-18	-22	-22	-19	-21	-18	-18
Income Tax Expense	0	1	0	-	-	0	-	-	-	-
Net Income	-14	-19	-16	-18	-22	-22	-19	-21	-18	-18
Net Profit Margin	0.00%	-1021.87%	0.00%	0.00%	0.00%	-2692.33%	0.00%	0.00%	0.00%	0.00%

Acrivon Therapeutics, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	0	0	-1	0	-1	-1
Operating Income	-3	-16	-32	-67	-89	-84
EBITDA	-5	-16	-32	-59	-79	-82
Interest Expense	-	0	1	-	-	-
Depreciation	0	0	0	0	1	1
Income Before Tax	-5	-16	-31	-60	-80	-77
Income Tax Expense	0	0	-1	0	-	-
Net Income	-5	-16	-29	-60	-80	-77
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Acrivon Therapeutics, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-19	-16	-18	-22	-22	-19	-21	-18	-18
Operating Cash Flow	-12	-17	-13	-17	-17	-19	-16	-12	-15
Investing Cash Flow	20	5	-88	16	14	19	19	5	21
Financing Cash Flow	-2	0	123	-1	0	0	0	0	0
Change in Cash	6	-11	21	-2	-3	0	2	-6	6

Acrivon Therapeutics, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-16	-31	-60	-80	-77
Operating Cash Flow	-13	-30	-42	-65	-63
Investing Cash Flow	0	-141	50	-51	66
Financing Cash Flow	112	101	-1	121	0
Change in Cash	98	-70	6	3	1

Global Institutional Holdings in Acrivon Therapeutics, Inc. Common Stock

Funds	Holdings
RA Capital Management, LLC	21.53%
Citadel Advisors Llc	4.24%
UBS Group AG	1.76%
Renaissance Technologies Corp	1.64%
Acadian Asset Management LLC	0.29%

See all

Insights on Acrivon Therapeutics, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, ACRV stock has moved up by 13.4%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 23.1% return, outperforming this stock by 107.3%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 38.8% return, outperforming this stock by 41.4%

About Acrivon Therapeutics, Inc. Common Stock

Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform. The company operates Acrivon Predictive Precision Proteomics (AP3), a precision medicine platform that enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2 for the treatment of patients with endometrial and platinum-resistant ovarian cancer, and SCCs, such as SCCHN and anal cancer. The company is also developing ACR-2316, a dual WEE1 and PKMYT1 inhibitor small molecule candidate; and a preclinical stage AP3-and co-crystallography-based preclinical cell cycle program. The company was incorporated in 2018 and is based in Watertown, Massachusetts.

Organisation	Acrivon Therapeutics, Inc. Common Stock
Headquarters	480 Arsenal Way, Watertown, MA, United States, 02472
Industry	Biotechnology
CEO	Dr. Peter Blume-Jensen M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Acrivon Therapeutics, Inc. Common Stock

Name	Title
Dr. Peter Blume-Jensen M.D., Ph.D.	Co-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer
Dr. Eric J. Devroe Ph.D.	Chief Operating Officer
Dr. Erick Gamelin M.D., Ph.D.	Chief Development Officer
Dr. Jesper V. Olsen Ph.D.	Academic Co-Founder, Head of Phosphoproteomics & Member of Scientific Advisory Board
Mr. Joon Jung Ph.D.	VP & Head of Data Science
Ms. Kristina Masson M.B.A., Ph.D.	Co-Founder, Executive VP of Business Operations, Site Head, Treasurer & Director
Dr. Adam D. Levy M.B.A., Ph.D.	CFO & Principal Financial Officer
Ms. Katharine Peterson CPA	Vice President of Finance & Accounting
Mr. Bruce Close	Vice President of Quality & Compliance
Ms. Mary-Alice Miller J.D.	Chief Legal Officer & Corporate Secretary

FAQs

What is Acrivon Therapeutics, Inc. Common Stock share price today?

Acrivon Therapeutics, Inc. Common Stock share price today is $1.76 as on April 22, 2026 at 1:29 am IST at the close of the market. Acrivon Therapeutics, Inc. Common Stock share today touched a day high of $1.87 and a low of $1.75.

What is the 52 week high and 52 week low for Acrivon Therapeutics, Inc. Common Stock share?

Acrivon Therapeutics, Inc. Common Stock share touched a 52 week high of $3.56 on January 7, 2026 and a 52 week low of $1.05 on June 2, 2025. Acrivon Therapeutics, Inc. Common Stock stock price today i.e. April 22, 2026 at 1:29 am IST is closed at $1.76,which is 50.56% down from its 52 week high and 67.62% up from its 52 week low.

What is Acrivon Therapeutics, Inc. Common Stock's market capitalisation today?

Acrivon Therapeutics, Inc. Common Stock market capitalisation is $0.00T as on April 22, 2026 at 1:29 am IST.

How to invest in Acrivon Therapeutics, Inc. Common Stock Stock (ACRV) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Acrivon Therapeutics, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Acrivon Therapeutics, Inc. Common Stock Shares that will get you 0.8523 shares as per Acrivon Therapeutics, Inc. Common Stock share price of $1.76 per share as on April 22, 2026 at 1:29 am IST.

What is the minimum amount required to buy Acrivon Therapeutics, Inc. Common Stock Stock (ACRV) from India?

Indian investors can start investing in Acrivon Therapeutics, Inc. Common Stock (ACRV) shares with as little as ₹93.505 or $1 (as of April 22, 2026 at 3:36 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹935.05 in Acrivon Therapeutics, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on April 22, 2026 at 3:36 am IST). Based on Acrivon Therapeutics, Inc. Common Stock share’s latest price of $1.76 as on April 22, 2026 at 1:29 am IST, you will get 5.6818 shares of Acrivon Therapeutics, Inc. Common Stock. Learn more about fractional shares .